Melphalan 200 mg/m 2 versus Melphalan 100 mg/m 2 in newly diagnosed myeloma patients: a prospective, multi-center phase III study.

Authors:

Palumbo A, Bringhen S, Bruno B, Falcone AP, Liberati AM, Grasso M, Ria R, Pisani F, Cangialosi C, Caravita T, Levi A, Meloni G, Nozza A, Pregno P, Gabbas A, Callea V, Rizzo M, Annino L, De Stefano V, Musto P, Baldi I , Cavallo F, Petrucci MT, Massaia M, Boccadoro M.

Source:

Blood 2010; 115: 1873-9.

This website only uses technical cookies and does not collect personal data or use profiling cookies. By continuing to browse, you accept the use of cookies.